Menu
Surfing the MASH Tsunami
Podcast image
S2-E41.2 - Specialties and Organizations Unite to Fight the NASH Epidemic
12 mins; August 14, 2021
S2-E41.1 - SPECIAL FEATURE: Interview with Louise Campbell
23 mins; August 13, 2021
S2-E41 - Preparing for the NASH Epidemic: Behind a Multidisciplinary Call to Action
51 mins; August 11, 2021
S2-E40.3 - Discussing Comprehensive Care Models For NAFLD - Metrics, Key Performance Indicators and Improving Management
14 mins; August 08, 2021
S2-E40.2 - Discussing Comprehensive Care Models For NAFLD - Providers Respond
16 mins; August 07, 2021
S2-E40.1 - Discussing Comprehensive Care Models for NAFLD - Jeff Lazarus Presents Research
13 mins; August 07, 2021
S2-E40 - Discussing Comprehensive Care Models for NAFLD
62 hours 50 mins; August 04, 2021
S2-E39.3 - 20K Celebration Interview With Jörn Schattenberg and Ian Rowe
42 mins; August 01, 2021
S2-E39.2 - 20K Celebration Interviews With Stephen Harrison and Naim Alkhouri
44 mins; July 31, 2021
S2-E39.1 - 20K celebration Interview with Donna Cryer
36 mins; July 31, 2021
S2-E39 - Celebrating Two Milestones for SurfingNASH!
58 mins; July 29, 2021
S2-E38.3 - Creating an Ecosystem of Community Physicians To Support Clinical Trials
14 mins; July 25, 2021
S2-E38.2 - Building a Culture That Encourages Patient Participation
12 mins; July 24, 2021
S2-E38.1 - Motivating Underserved Patients to Participate in Clinical Trials
13 mins; July 24, 2021
S2-E38 - Increasing Diversity in the Clinical Trial Patient Population
41 mins; July 21, 2021
S2-E37.3 - Spreading the NASH Message Throughout the Broader Community Of Healthcare Practitioners
11 mins; July 18, 2021
S2-E37.2 - NASH Diagnostics Provide a Natural Brake on Overly Broad Adoption of NASH Drugs
15 mins; July 17, 2021
S2-E37.1 - Key Reasons the NASH Drug Market Will Evolve Differently From Statins
11 mins; July 17, 2021
S2-E37 - Why the NASH Market Is Different From Statins
58 mins; July 14, 2021
S2-E36.3 - From the #ILC2021 Wrap-up: Focus on Care Pathways and Treatment Roles
11 mins; July 04, 2021
S2-E36.2 - From The #ILC2021 Wrap-Up: Focus On Drug Development
13 mins; July 03, 2021
S2-E36.1 - From the #ILC2021 Wrap-up: Focus on Diagnostics
16 mins; July 03, 2021
S2-E36 - #ILC2021 Wrap-Up: Big Issues, Key Takeaways, Remaining Issues
57 mins; June 30, 2021
S2-E35 - #ILC2021 Day Four - Promising Times Ahead, Maybe With a Few More Bumps In the Road
73 hours 35 mins; June 26, 2021
S2-E34 - #ILC2021 Day Three - Multi-Disciplinary NAFLD Thinking, with Exciting Drugs on the Horizon
73 hours 58 mins; June 25, 2021
S2-E32 - Leaders Provide Perspectives on #ILC2021
58 mins; June 24, 2021
S2-E33 - #ILC2021 Day Two -- Learning About Patients Through Large Databases
74 hours 11 mins; June 24, 2021
S2-E31.3 - Previewing Digital ILC 2021 -- Part II -- NITs, late-breakers and intriguing topics
12 mins; June 20, 2021
S2-E31.2 - Previewing Digital ILC 2021 -- Part II -- Drug Development
12 mins; June 19, 2021
S2-E31.1 - Previewing Digital ILC 2021 -- Part II -- "Favorite Things" and Discussing Metabolic issues
14 mins; June 19, 2021
S2-E31 - DIgital ILC 2021 -- Preview II
44 mins; June 16, 2021
S2-E30.3 - The Global Liver institute US NASH Action Plan - treatment and health system challenges
16 mins; June 13, 2021
S2-E30.2 - The Global Liver Institute US NASH Action Plan - Common, Reliable Diagnostics Are Critical
14 mins; June 12, 2021
S2-E30.1 - The Global Liver Institute US NASH Action Plan - Overview And What Education Must Achieve
16 mins; June 12, 2021
S2-E30 - The Global Liver institute US NASH Action Plan - What It Is and How We All Can Help Support it
60 hours 18 mins; June 10, 2021
S2-E29.3 - Previewing Digital ILC 2021 -- Part 1 -- What might emerge?
12 mins; June 06, 2021
S2-E29.2 - Previewing Digital ILC 2021 -- Part 1 -- Interests and Issues
12 mins; June 05, 2021
S2-E29.1 - Previewing Digital ILC 2021 -- Part 1 -- Meeting Overview
12 mins; June 05, 2021
S2-E29 - Previewing Digital ILC 2021 -- Part 1
42 mins; June 02, 2021
S2-E27.2 - A Deeper Look At International NASH Day 2021 -- Activities, Future Plans, And Global Liver Institute Growth
20 mins; May 29, 2021
S2-E27.1 - previewing International nASH day 2021 -- overview of events
14 mins; May 29, 2021
S2 - E28 - SPECIAL EPISODE: What Can We Learn The Aldafermin Discontinuation In F2/F3 NASH?
25 mins; May 27, 2021
S2-E27 - Previewing International NASH Day -- a growing Day of Global Education and Organizing
38 mins; May 26, 2021
S2-E26.3 - How much will real-life NASH treatment decisions depend on the specialty of the prescriber?
18 mins; May 23, 2021
S2-E26.2 - How simply "Vertebrate" will future NASH therapy be?
14 mins; May 22, 2021
S2-E26.1 - What will NASH Pharmacotherapy Look Like When we have Multiple Options?
12 mins; May 22, 2021
S2-E26 - What Will Treatment Pathways Look Like For NASH Patients?
50 mins; May 19, 2021
S2-E25.1 (CORRECTED) - Prevalence of NAFLD and NASH 2021 -- Key Findings
14 mins; May 17, 2021
S2-E25.2 (CORRECTED) - Prevalence of NAFLD and NASH 2021 -- Deeper Dive
14 mins; May 17, 2021
S2-E25.3 (CORRECTED) - Prevalence of NAFLD and NASH 2021 -- An Urgent Call to Action
20 mins; May 17, 2021
S2-E25 - How many Americans Are Living with NAFLD and NASH?
54 mins; May 12, 2021
S2-E24.3 - From The Fourth Global NASH Congress -- How Diagnostics Will Evolve Over The Next Several Years
15 mins; May 09, 2021
S2-E24.2 - From The Fourth Global NASH Congress -- How Treatment WIll Evolve Over The Next Several Years
10 mins; May 08, 2021
S2-E24.1 - From the Fourth Global NASH Congress -- Changing Paradigms and Guidelines
16 mins; May 08, 2021
S2-E24 - Fourth Global NASH Congress -- Wrapping Up
52 mins; May 05, 2021
S2-E23.1 - From the Fourth Global NASH Congress -- Diagnosing Diagnostics
34 mins; May 03, 2021
S2-E23 - Wrapping up Day Two of the Fourth Global NASH Congress -- Drugs, lifestyles and Health policy
44 mins; May 01, 2021
S2-E22 - Day Two at the 4th Global NASH Congress -- many New Drugs and Non-Pharmacologic Interventions
42 mins; April 29, 2021
S2-E21 - Day One At The 4th Global NASH Congress -- Diagnostics, Drugs And Regulatory Issues
61 hours 47 mins; April 28, 2021
S2-E20.3 - How Can we Best Use NASHmap in Clinical trials and Patient Treatment?
15 mins; April 25, 2021
S2-E20.2 - What Can We Learn about NASH From NASHmap?
21 mins; April 24, 2021
S2-E20 - 14-variable Machine Learning model identifies Probable NASH patients from Electronic Health Records
53 mins; April 21, 2021
S2-E20.1 - How NASHmap, the 1st Machine Learning Model to Identify Probable NASH Patients, Came to Life
12 mins; April 21, 2021
S2-E19.3 - Pharmacotherapy Themes At The 4th Global NASH Congress
12 mins; April 18, 2021
S2-E19.2 - Patient-Centric Themes At The 4th Global NASH Congress
16 mins; April 17, 2021
S2-E19.1 - Non-Invasive Testing Themes at the 4th Global NASH Congress
13 mins; April 17, 2021
S2-E19 - Previewing the 4th Global NASH congress
47 mins; April 14, 2021
S2 E18.3 -- Stephen Harrison and Alina Allen discuss what her work portends for future trials.
20 mins; April 11, 2021
S2 E18.2 -- How Might We Treat Differently If We Knew Which Cirrhotic Patients Are Likely To Progress?
23 mins; April 10, 2021
S2 E18.1 -- How Does MR Elastography Help Identify NASH PAtients Who Are Likely To Progress?
15 mins; April 10, 2021
S2-E18 - Magnetic Resonance Elastography Predicts Prognosis for NASH patients
69 hours 12 mins; April 07, 2021
S2-E17.3 -- The value of ultrasound and the goals of patient screenin
14 mins; April 04, 2021
S2-E17.2 — Modeling the relative impact of treating NASH vs. CVD in patients with different fibrosis levels
13 mins; April 03, 2021
S2-E17.1 - Questions in Screening: Do Liquid Tests Bring Better Value than Elastography?
20 mins; April 03, 2021
S2-E17 - New lessons from Leeds: Streamlining Non-Invasive Testing algorithms
58 mins; March 31, 2021
S2-E16.3 - How NASH treatment Might Evolve as Therapies Come to Market
16 mins; March 28, 2021
S2-E16.2 - Future Directions for NASH Cost-Effectiveness Research
14 mins; March 27, 2021
S2 E16.1 -- How Cost-Effectiveness Research On Widespread NIT Screening In The U.S. Has Evolved
17 mins; March 27, 2021
S2-E16 -- Cost-Effectiveness of Widespread Non-Invasive NASH Testing and Treatment
54 mins; March 24, 2021
S2-E15 — Wrapping Up NASH-TAG 2021
52 mins; March 17, 2021
S2-E14 - NASH-TAG Session 4 Summary: Basic Science and Promising Drugs on the Horizon
47 mins; March 14, 2021
S2-E13 - NASH-TAG Session 3 Summary: Trial Designs of the Future and the Future of Diabetes Drugs in NASH
49 mins; March 14, 2021
S2-E12 - NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses
48 mins; March 13, 2021
S2 E11 — NASH-TAG Session 1 summary: Major Drugs in Development and Why Trials Fail
50 mins; March 12, 2021
S2 E10 — Before NASH-TAG, Conversations With Co-Directors
40 mins; March 10, 2021
S2-E9.2—Drug-Free Treatment of Early Fatty Liver Disease: Issues for Public Health
12 mins; March 07, 2021
S2-E9.1—Drug-Free Treatment of Early Fatty Liver Disease: Identity matters
12 mins; March 06, 2021
S2-E9.3 — Introducing LIVErHEALTHY: a program for patients with Early Fatty Liver disease
32 mins; March 06, 2021
S2-E9 - Novel Approaches to Drug-Free Treatment of Early Fatty Liver Disease
65 hours 54 mins; March 04, 2021
S2-E8.3 - Previewing NASH-TAG 2021: Two intriguing side conversations
17 mins; February 27, 2021
S2-E8.2 - Previewing NASH-TAG 2021: Day Two
13 mins; February 27, 2021
S2-E8.1 - Previewing NASH-TAG 2021: Day One
17 mins; February 27, 2021
S2-E8 - Previewing NASH-TAG 2021
54 mins; February 24, 2021
S2-E7.3 - The newer diabetes drugs and NASH: Educating and Motivating Stakeholders
12 mins; February 20, 2021
S2-E7.2 - The Newer Diabetes Drugs and NASH: How T2D Patients are likely to respond
13 mins; February 20, 2021
S2-E7.1 - The Newer Diabetes Drugs and NASH: Modes of Action
16 mins; February 20, 2021
S2-E7 - The Newer Diabetes Drugs and Patients with NASH
49 mins; February 17, 2021
S2 E6.3 - #RealTalk: Trial Recruiting Challenges: Traps to Avoid in designing patient protocols for NASH Trials
24 mins; February 14, 2021
S2 E6.2 - #RealTalk: Trial Recruiting Challenges: Educating Physician during the pandemic
12 mins; February 13, 2021
S2 E6.1 - #RealTalk: Trial Recruiting Challenges: Daunting Numbers and Challenging Protocols
15 mins; February 13, 2021
Click here to see more
Useful pages

Apply to teach

Reviews

Help & FAQs

Blog

Spanish Podcast

French Podcast

Italian Podcast

About Us

Contact Us

Terms & Privacy

Find a tutor

Arabic tutors

Chinese tutors

Dutch tutors

English tutors

French tutors

German tutors

Greek tutors

Italian tutors

Japanese tutors

Korean tutors

Portuguese tutors

Romanian tutors

Russian tutors

Spanish tutors

Swedish tutors

Thai tutors

More languages soon!

Languages

Learn Arabic

Learn Chinese

Learn Dutch

Learn English

Learn French

Learn German

Learn Greek

Learn Italian

Learn Japanese

Learn Korean

Learn Portuguese

Learn Romanian

Learn Russian

Learn Spanish

Learn Swedish

Learn Thai

© 2026 LanguaTalk, All Rights Reserved